VNDA - Vanda Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VNDA is currently covered by 2 analysts with an average price target of $10.09. This is a potential upside of $5.19 (105.92%) from yesterday's end of day stock price of $4.9.

Vanda Pharmaceuticals's activity chart (see below) currently has 51 price targets and 33 ratings on display. The stock rating distribution of VNDA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 78.17% with an average time for these price targets to be met of 454.5 days.

Highest price target for VNDA is $13, Lowest price target is $13, average price target is $10.09.

Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 01-Aug-2024. First documented stock forecast 17-Jan-2013.

Currently out of the existing stock ratings of VNDA, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13

$8 (160.00%)

$11

3 months 19 days ago
(01-Aug-2024)

3/7 (42.86%)

$7.36 (130.50%)

320

Hold

$12

$7 (140.00%)

$24

2 years 8 months 26 days ago
(25-Feb-2022)

2/4 (50%)

$0.82 (7.33%)

46

Hold

$18

$13 (260.00%)

$14

3 years 9 months 9 days ago
(11-Feb-2021)

8/9 (88.89%)

$-0.67 (-3.59%)

235

Sell

$7

$2 (40.00%)

$12

4 years 8 months 4 days ago
(16-Mar-2020)

4/4 (100%)

$-1.1 (-13.58%)

285

Buy

$25

$20.66 (476.04%)

$52

4 years 8 months 26 days ago
(26-Feb-2020)

1/3 (33.33%)

$14.34 (78.91%)

446

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VNDA (Vanda Pharmaceuticals) average time for price targets to be met?

On average it took 454.5 days on average for the stock forecasts to be realized with a an average price target met ratio 78.17

Which analyst has the current highest performing score on VNDA (Vanda Pharmaceuticals) with a proven track record?

DEREK ARCHILA

Which analyst has the most public recommendations on VNDA (Vanda Pharmaceuticals)?

Derek Archila works at WELLS FARGO and has 5 price targets and 3 ratings on VNDA

Which analyst is the currently most bullish on VNDA (Vanda Pharmaceuticals)?

Jason Butler with highest potential upside - $20.66

Which analyst is the currently most reserved on VNDA (Vanda Pharmaceuticals)?

Esther Rajavelu with lowest potential downside - $2

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?